Legis Daily

FAUCI Act

USA117th CongressHR-5988| House 
| Updated: 11/17/2021
Chris Stewart

Chris Stewart

Republican Representative

Utah

Cosponsors (2)
Ronny Jackson (Republican)Nicole Malliotakis (Republican)

Foreign Affairs Committee, Health Subcommittee, Science, Space, and Technology Committee, Energy and Commerce Committee, Oversight and Government Reform Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Fairness and Accountability in Underwriting Chinese Institutions Act or the FAUCI Act This bill prohibits making any federal funding available to laboratories or research institutions in China for gain-of-function research. The President may waive this prohibition for national security interests. (Under the bill, gain-of-function research generally involves the enhancement of potential pandemic pathogens or related risky research with potentially dangerous pathogens.) Furthermore, if the Office of the Inspector General of the Department of Health and Human Services determines that a National Institutes of Health official, employee, or grantee has intentionally misled or omitted information in a relevant disclosure (e.g., to Congress) about federal funding for international gain-of-function research, such a person shall be ineligible for any federal funding or federal employment.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Nov 16, 2021
Introduced in House
Nov 16, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Science, Space, and Technology, Oversight and Reform, and Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Nov 17, 2021
Referred to the Subcommittee on Health.
Jan 19, 2022

Latest Companion Bill Action

S 117-3523
Introduced in Senate
  • November 16, 2021
    Introduced in House


  • November 16, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committees on Science, Space, and Technology, Oversight and Reform, and Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • November 17, 2021
    Referred to the Subcommittee on Health.


  • January 19, 2022

    Latest Companion Bill Action

    S 117-3523
    Introduced in Senate

International Affairs

Related Bills

  • S 117-3159: FAUCI Act
AsiaCardiovascular and respiratory healthChinaCongressional oversightDepartment of Health and Human ServicesDrug trafficking and controlled substancesGovernment employee pay, benefits, personnel managementGovernment ethics and transparency, public corruptionGovernment studies and investigationsHealth programs administration and fundingInfectious and parasitic diseasesMedical researchNational Institutes of Health (NIH)Public contracts and procurementResearch administration and fundingWorld health

FAUCI Act

USA117th CongressHR-5988| House 
| Updated: 11/17/2021
Fairness and Accountability in Underwriting Chinese Institutions Act or the FAUCI Act This bill prohibits making any federal funding available to laboratories or research institutions in China for gain-of-function research. The President may waive this prohibition for national security interests. (Under the bill, gain-of-function research generally involves the enhancement of potential pandemic pathogens or related risky research with potentially dangerous pathogens.) Furthermore, if the Office of the Inspector General of the Department of Health and Human Services determines that a National Institutes of Health official, employee, or grantee has intentionally misled or omitted information in a relevant disclosure (e.g., to Congress) about federal funding for international gain-of-function research, such a person shall be ineligible for any federal funding or federal employment.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Nov 16, 2021
Introduced in House
Nov 16, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Science, Space, and Technology, Oversight and Reform, and Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Nov 17, 2021
Referred to the Subcommittee on Health.
Jan 19, 2022

Latest Companion Bill Action

S 117-3523
Introduced in Senate
  • November 16, 2021
    Introduced in House


  • November 16, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committees on Science, Space, and Technology, Oversight and Reform, and Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • November 17, 2021
    Referred to the Subcommittee on Health.


  • January 19, 2022

    Latest Companion Bill Action

    S 117-3523
    Introduced in Senate
Chris Stewart

Chris Stewart

Republican Representative

Utah

Cosponsors (2)
Ronny Jackson (Republican)Nicole Malliotakis (Republican)

Foreign Affairs Committee, Health Subcommittee, Science, Space, and Technology Committee, Energy and Commerce Committee, Oversight and Government Reform Committee

International Affairs

Related Bills

  • S 117-3159: FAUCI Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
AsiaCardiovascular and respiratory healthChinaCongressional oversightDepartment of Health and Human ServicesDrug trafficking and controlled substancesGovernment employee pay, benefits, personnel managementGovernment ethics and transparency, public corruptionGovernment studies and investigationsHealth programs administration and fundingInfectious and parasitic diseasesMedical researchNational Institutes of Health (NIH)Public contracts and procurementResearch administration and fundingWorld health